Docosahexaenoic acid supplementation in gestational diabetes mellitus and neonatal metabolic health biomarkers

HIGHLIGHTS

  • who: ufeffYa-Jieufeff ufeffXuufeff et al. from the United States University of Belgrade have published the research: Docosahexaenoic acid supplementation in gestational diabetes mellitus and neonatal metabolic health biomarkers, in the Journal: (JOURNAL)
  • how: The authors conducted a randomized trial to test the hypothesis that DHA supplementation in GDM may affect neonatal metabolic health biomarkers especially leptin and adiponectin.

SUMMARY

    Gestational diabetes_mellitus (GDM) is a common pregnancy complication characterized by de novo hyperglycemia in the second half of pregnancy. The study was approved by the Research Ethics Committee of Xinhua Abbreviations . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?